We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

14 hedge funds and large institutions have $1.1M invested in Dare Bioscience in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more capital invested

Capital invested by funds: $519K → $1.1M (+$586K)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.04% more ownership

Funds ownership: 0.54% → 0.58% (+0.04%)

13% less funds holding

Funds holding: 16 → 14 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$44.7K
2
Renaissance Technologies
Renaissance Technologies
New York
+$43.4K
3
TSS
Two Sigma Securities
New York
+$20.4K
4
Citadel Advisors
Citadel Advisors
Florida
+$15.8K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.5K

Top Sellers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
-$16.5K
2
VF
Virtu Financial
New York
-$15K
3
PAM
Panagora Asset Management
Massachusetts
-$14K
4
Barclays
Barclays
United Kingdom
-$10K
5
PP
Paloma Partners
Connecticut
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
PVMCV
1
Polaris Venture Management Co V
Massachusetts
$457K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$250K +$43.4K +3,733 +34%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$147K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$65K +$5.06K +435 +13%
Jane Street
5
Jane Street
New York
$65K +$44.7K +3,844 New
TSS
6
Two Sigma Securities
New York
$29K +$20.4K +1,753 New
BFM
7
Boothbay Fund Management
New York
$26K -$16.5K -1,418 -48%
Citadel Advisors
8
Citadel Advisors
Florida
$23K +$15.8K +1,355 New
Northern Trust
9
Northern Trust
Illinois
$15K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$15K +$10.5K +906 New
UBS Group
11
UBS Group
Switzerland
$10K +$2.18K +187 +45%
AWA
12
Artemis Wealth Advisors
New York
$1.23K – – –
BlackRock
13
BlackRock
New York
$1K – – –
VF
14
Virtu Financial
New York
– -$15K -1,783 Closed
PAM
15
Panagora Asset Management
Massachusetts
– -$14K -1,626 Closed
Barclays
16
Barclays
United Kingdom
– -$10K -1,167 Closed
PP
17
Paloma Partners
Connecticut
– -$9K -1,075 Closed
Macquarie Group
18
Macquarie Group
Australia
– -$5K -575 Closed
Morgan Stanley
19
Morgan Stanley
New York
– -$81 -7 -58%

DARE Hedge Fund Activity: Q1 2019 in Review

14 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2019, worth a combined $1.1M — up 113% from $519K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of DARE and 4 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Jane Street, opening a new position worth an estimated $44.7K. The largest seller was Boothbay Fund Management, cutting an estimated $16.5K.

  • 14 institutional investors held Dare Bioscience (DARE) as of Q1 2019, down from 16 in Q4 2018.
  • Funds reported $1.1M of Dare Bioscience stock for Q1 2019, up 113% quarter-over-quarter.
  • 4 funds opened new Dare Bioscience positions in Q1 2019 and 6 closed out, a net change of -2 holders.
  • The largest Dare Bioscience buyer in Q1 2019 was Jane Street, an estimated $44.7K added.
  • The largest Dare Bioscience seller in Q1 2019 was Boothbay Fund Management, an estimated $16.5K sold.

Based on aggregated 13F filings for Q1 2019.